Interleukin-6 in the injured patient marker of injury or mediator of inflammation?

被引:457
作者
Biffl, WL
Moore, EE
Moore, FA
Peterson, VM
机构
[1] DENVER GEN HOSP, DEPT SURG, DENVER, CO 80204 USA
[2] UNIV COLORADO, HLTH SCI CTR, DENVER, CO USA
关键词
D O I
10.1097/00000658-199611000-00009
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective The effects of interleukin (IL)-6 in the injured patient are examined in an attempt to clarify the potential pathophysiologic role of IL-6 in the response to injury. Summary Background Data Interleukin-6 is an integral cytokine mediator of the acute phase response to injury and infection. However, prolonged and excessive elevations of circulating IL-6 levels in patients after trauma, burns, and elective surgery have been associated with complications and mortality. The mechanistic role of IL-6 in mediating these effects is unclear. Methods A review of current literature is performed to summarize the origins, mechanisms of action, and biologic effects of IL-6 and to characterize the IL-6 response to injury. Results Interleukin-6 is a multifunctional cytokine expressed by a variety of cells after a multitude of stimuli, under complex regulatory control mechanisms. The IL-6 response to injury is uniquely consistent and related to the magnitude of the insult. Moreover, the early postinjury IL-6 response correlates with complications as well as mortality. Conclusions Interleukin-6 appears to play an active role in the postinjury immune response, making it an attractive therapeutic target in attempts to control hyperinflammatory provoked organ injury.
引用
收藏
页码:647 / 664
页数:18
相关论文
共 256 条
[91]   COMPLEMENT ACTIVATION AND HEMATOLOGIC, HEMODYNAMIC, AND RESPIRATORY REACTIONS EARLY AFTER SOFT-TISSUE INJURY [J].
HEIDEMAN, M ;
KAIJSER, B ;
GELIN, LE .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1978, 18 (10) :696-700
[92]   INTERLEUKIN-6 AND THE ACUTE PHASE RESPONSE [J].
HEINRICH, PC ;
CASTELL, JV ;
ANDUS, T .
BIOCHEMICAL JOURNAL, 1990, 265 (03) :621-636
[93]  
HELFGOTT DC, 1989, J IMMUNOL, V142, P948
[94]   INTERLEUKIN-6 IS INVOLVED IN INTERLEUKIN-1-INDUCED ACTIVITIES [J].
HELLE, M ;
BRAKENHOFF, JPJ ;
DEGROOT, ER ;
AARDEN, LA .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (06) :957-959
[95]   EXPRESSION OF FUNCTIONAL RECEPTORS FOR INTERLEUKIN-6 BY HUMAN POLYMORPHONUCLEAR LEUKOCYTES - DOWN-REGULATION BY GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR [J].
HENSCHLER, R ;
LINDEMANN, A ;
BRACH, MA ;
MACKENSEN, A ;
MERTELSMANN, RH ;
HERRMANN, F .
FEBS LETTERS, 1991, 283 (01) :47-51
[96]   MOLECULAR-CLONING AND EXPRESSION OF AN IL-6 SIGNAL TRANSDUCER, GP130 [J].
HIBI, M ;
MURAKAMI, M ;
SAITO, M ;
HIRANO, T ;
TAGA, T ;
KISHIMOTO, T .
CELL, 1990, 63 (06) :1149-1157
[97]  
HILL J, 1992, SURGERY, V112, P166
[98]   COMPLEMENTARY-DNA FOR A NOVEL HUMAN INTERLEUKIN (BSF-2) THAT INDUCES LYMPHOCYTES-B TO PRODUCE IMMUNOGLOBULIN [J].
HIRANO, T ;
YASUKAWA, K ;
HARADA, H ;
TAGA, T ;
WATANABE, Y ;
MATSUDA, T ;
KASHIWAMURA, S ;
NAKAJIMA, K ;
KOYAMA, K ;
IWAMATSU, A ;
TSUNASAWA, S ;
SAKIYAMA, F ;
MATSUI, H ;
TAKAHARA, Y ;
TANIGUCHI, T ;
KISHIMOTO, T .
NATURE, 1986, 324 (6092) :73-76
[99]   PURIFICATION TO HOMOGENEITY AND CHARACTERIZATION OF HUMAN B-CELL DIFFERENTIATION FACTOR (BCDF OR BSFP-2) [J].
HIRANO, T ;
TAGA, T ;
NAKANO, N ;
YASUKAWA, K ;
KASHIWAMURA, S ;
SHIMIZU, K ;
NAKAJIMA, K ;
PYUN, KH ;
KISHIMOTO, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (16) :5490-5494
[100]   HUMAN B-CELL DIFFERENTIATION FACTOR DEFINED BY AN ANTIPEPTIDE ANTIBODY AND ITS POSSIBLE ROLE IN AUTOANTIBODY PRODUCTION [J].
HIRANO, T ;
TAGA, T ;
YASUKAWA, K ;
NAKAJIMA, K ;
NAKANO, N ;
TAKATSUKI, F ;
SHIMIZU, M ;
MURASHIMA, A ;
TSUNASAWA, S ;
SAKIYAMA, F ;
KISHIMOTO, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (01) :228-231